Are hepatocytes endocrine cells?

References

[1] MeexRCR.Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.Nat Rev Endocrinol2017;13:509-20

[2] WattMJ,DeNardo W.The liver as an endocrine organ-linking NAFLD and insulin resistance.Endocrine Reviews2019;40:1367-93

[3] StefanN,BirkenfeldAL,WhiteMF.The role of hepatokines in NAFLD.Cell Metab2023;35:236-52

[4] FlippoKH.Metabolic messengers: FGF21.Nat Metab2021;3:309-17 PMCID:PMC8620721

[5] SongWJ,WolfeA.Glucagon regulates hepatic kisspeptin to impair insulin secretion.Cell Metab2014;19:667-81 PMCID:PMC4058888

[6] MeexRC,MorrisA.Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism.Cell Metab2015;22:1078-89

[7] ElOuaamari A,GedeonN.SerpinB1 promotes pancreatic β cell proliferation.Cell Metab2016;23:194-205 PMCID:PMC4715773

[8] TaoR,StöhrO.Inactivating hepatic follistatin alleviates hyperglycemia.Nat Med2018;24:1058-69 PMCID:PMC6039237

[9] GongXM,LuoJ.Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance.Nat Metab2019;1:570-83

[10] WangQ,ShenH.The hepatokine Tsukushi gates energy expenditure via brown fat sympathetic innervation.Nat Metab2019;1:251-60 PMCID:PMC6750233

[11] MontgomeryMK,DevereuxC.SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control.Sci Transl Med2020;12:eaaz8048

[12] ZhouB,JiN,LuY.Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis.Nat Metab2022;4:1185-201

[13] KalraS,RawalP.Hepatocrinology.Med Sci (Basel)2021;9:39 PMCID:PMC8293374